PEDIATRICS Vol. 122 No. 5 November 2008, pp. 1064-1071 (doi:10.1542/peds.2007-3770)
ARTICLE |
Prophylaxis After First Febrile Urinary Tract Infection in Children? A Multicenter, Randomized, Controlled, Noninferiority Trial
Departments of a Pediatric Nephrology
b Nuclear Medicine
c Pediatrics
e Epidemiology Unit
p Pediatric Emergency Department, Azienda Ospedaliera-University of Padua, Italy; Pediatric Unit
d Oderzo
f Castelfranco Veneto
g Bologna
h Mestre-Venezia
i Soave
j Bolzano
k Ravenna
l Piove di Sacco-Chioggia
m Verona-Borgo Trento
n Bentivoglio
q Thiene, Italy
o General Practitioner, San Donà di Piave-Venezia, Italy
OBJECTIVES. Febrile urinary tract infections are common in children and associated with the risk for renal scarring and long-term complications. Antimicrobial prophylaxis has been used to reduce the risk for recurrence. We performed a study to determine whether no prophylaxis is similar to antimicrobial prophylaxis for 12 months in reducing the recurrence of febrile urinary tract infections in children after a first febrile urinary tract infection.
METHODS. The study was a controlled, randomized, open-label, 2-armed, noninferiority trial comparing no prophylaxis with prophylaxis (co-trimoxazole 15 mg/kg per day or co-amoxiclav 15 mg/kg per day) for 12 months. A total of 338 children who were aged 2 months to <7 years and had a first episode of febrile urinary tract infection were enrolled: 309 with a confirmed pyelonephritis on a technetium 99m dimercaptosuccinic acid scan with or without reflux and 27 with a clinical pyelonephritis and reflux. The primary end point was recurrence rate of febrile urinary tract infections during 12 months. Secondary end point was the rate of renal scarring produced by recurrent urinary tract infections on technetium 99m dimercaptosuccinic acid scan after 12 months.
RESULTS. Intention-to-treat analysis showed no significant differences in the primary outcome between no prophylaxis and prophylaxis: 12 (9.45%) of 127 vs 15 (7.11%) of 211. In the subgroup of children with reflux, the recurrence of febrile urinary tract infections was 9 (19.6%) of 46 on no prophylaxis and 10 (12.1%) of 82 on prophylaxis. No significant difference was found in the secondary outcome: 2 (1.9%) of 108 on no prophylaxis versus 2 (1.1%) of 187 on prophylaxis. Bivariate analysis and Cox proportional hazard model showed that grade III reflux was a risk factor for recurrent febrile urinary tract infections. Whereas increasing age was protective, use of no prophylaxis was not a risk factor.
CONCLUSIONS. For children with or without primary nonsevere reflux, prophylaxis does not reduce the rate of recurrent febrile urinary tract infections after the first episode.
Key Words: urinary tract infection antibiotic prophylaxis renal scar DMSA scan
Abbreviations: UTI—urinary tract infection RR—relative risk CI—confidence interval VUR—vesicoureteral reflux ITT—intention-to-treat DMSA—dimercaptosuccinic acid VCUG—voiding cystourethrography IQR—interquartile range
Accepted Mar 3, 2008.
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
This article has been cited by other articles:
![]() |
J. C. Craig, J. M. Simpson, G. J. Williams, A. Lowe, G. J. Reynolds, S. J. McTaggart, E. M. Hodson, J. R. Carapetis, N. E. Cranswick, G. Smith, et al. Antibiotic Prophylaxis and Recurrent Urinary Tract Infection in Children N. Engl. J. Med., October 29, 2009; 361(18): 1748 - 1759. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Hoberman and R. Keren Antimicrobial Prophylaxis for Urinary Tract Infection in Children N. Engl. J. Med., October 29, 2009; 361(18): 1804 - 1806. [Full Text] [PDF] |
||||
![]() |
G. Lackgren and A. Stenberg Endoscopic treatment of vesicoureteral reflux: current practice and the need for multifactorial assessment Therapeutic Advances in Urology, August 1, 2009; 1(3): 131 - 141. [Abstract] [PDF] |
||||
![]() |
H. Bauchner Atoms Arch. Dis. Child., April 1, 2009; 94(4): i - i. [Full Text] [PDF] |
||||
![]() |
M. H. Rathore Prophylaxis After First UTI May Not Be Necessary AAP Grand Rounds, March 1, 2009; 21(3): 26 - 26. [Full Text] [PDF] |
||||
![]() |
I. K. Hewitt and G. Montini Treatment of Pyelonephritis and Risk of Renal Scarring: In Reply Pediatrics, March 1, 2009; 123(3): e545 - e545. [Full Text] [PDF] |
||||
![]() |
G. Montini, P. Zucchetta, L. Tomasi, E. Talenti, W. Rigamonti, G. Picco, A. Ballan, A. Zucchini, L. Serra, V. Canella, et al. Value of Imaging Studies After a First Febrile Urinary Tract Infection in Young Children: Data From Italian Renal Infection Study 1 Pediatrics, February 1, 2009; 123(2): e239 - e246. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Travan, M. Pennesi, and L. Ronfani Is Antibiotic Prophylaxis in Children With Vesicoureteral Reflux Effective in Preventing Pyelonephritis and Renal Scars? A Randomized, Controlled Trial: In Reply Pediatrics, December 1, 2008; 122(6): 1410 - 1411. [Full Text] [PDF] |
||||
![]() |
Does Antibiotic Prophylaxis Prevent UTI Recurrence in Children? Journal Watch (General), November 13, 2008; 2008(1113): 7 - 7. [Full Text] |
||||











